DaVita Inc. (NYSE: DVA) reported fourth-quarter revenue and profit that surpassed analyst forecasts, driven by strategic pricing and operational efficiency. The results sent shares sharply higher as the dialysis giant navigates a complex regulatory and demographic landscape.
Bernstein analyst lifts ASML's price target to $1,911, citing a buying opportunity after recent pullback. The chip equipment giant's record Q4 orders and updated guidance signal confidence in the AI-driven semiconductor upcycle.
As Palantir Technologies prepares to report Q4 results, soaring demand for its AI platform collides with sky-high valuations, leaving investors to weigh robust growth against bubble fears.
Craig-Hallum and Northland Securities have both lowered price targets for MiMedx Group (MDXG), citing near-term uncertainty following new CMS billing guidance for skin substitute products, though both firms maintain positive long-term ratings.
CNBC's Jim Cramer offered a mixed review of ServiceNow, praising its management and cloud platform while expressing deep frustration with the stock's recent performance, calling it a 'nightmare' for investors.
As Reddit prepares to report its fourth-quarter results on February 5th, investors are weighing its surging user growth and lucrative data-licensing deals against a sky-high valuation and a volatile market backdrop.
As AMD prepares to report its Q4 2025 results, robust data center demand and ramping MI350 AI chip deployments paint a bullish picture. Yet, heavy investment costs and a history of post-earnings stock dips suggest investors should temper expectations.
U.S. stocks advanced cautiously Monday as investors braced for a wave of corporate earnings reports, while crude oil prices tumbled sharply. The focus remains on key tech results and evolving geopolitical developments affecting global trade and energy markets.
While Medtronic's shares have trailed the S&P 500 over the past year, Wall Street maintains a cautiously optimistic stance, buoyed by strong recent earnings and raised guidance.
ASML Holding NV has launched a massive new share repurchase program and reaffirmed strong sales guidance, as record AI-related equipment orders fuel optimism about the Dutch tech giant's central role in the semiconductor industry's future.
As the seasonal spectacle of Groundhog Day passes, the Nasdaq faces a more substantive test. With tech earnings under a microscope and macroeconomic uncertainty lingering, investors are weighing robust historical patterns against near-term caution.
Despite posting record membership, revenue, and a landmark $1 billion quarter, SoFi Technologies' stock faces a steep pullback. While Wall Street maintains a cautious 'Hold,' the company's strategic pivot and robust forecasts suggest the current dip may present a compelling entry point for growth investors.
Tyson Foods reported mixed Q1 FY2026 results, with strong momentum in Prepared Foods and Chicken segments offset by significant challenges in Beef due to constrained cattle supplies. The company also unveiled a new segment reporting structure aimed at enhancing transparency for investors.
Life sciences and diagnostics firm Revvity (RVTY) closed 2025 with results surpassing internal targets, driven by robust diagnostics performance. While management provided initial 2026 guidance, it remains conservative, banking on market stabilization rather than a broad recovery.
As major indices climb, investors are sifting through economic crosscurrents to find resilient tech innovators. We examine three companies—Veracyte, monday.com, and Zeta Global—whose strategic moves and financial momentum position them for potential growth.
Alliance Resource Partners (ARLP) posted a significant jump in fourth-quarter profit, driven by cost controls and investment gains, even as coal revenue softened. The partnership issued 2026 guidance pointing to robust contract coverage and a growing oil & gas royalty segment, while navigating challenges at a key Appalachian mine.
Amid market volatility driven by AI speculation, a seasoned investor makes the case for a dual-anchor strategy built on Apple's surging iPhone sales and Berkshire Hathaway's formidable $378 billion cash reserve.
Merck & Co. is set to report fourth-quarter 2025 results before the bell on Tuesday, with Wall Street anticipating steady growth. The pharmaceutical giant's shares have climbed 13% over the past year, outpacing the broader healthcare sector. All eyes will be on Keytruda's sales trajectory and management's guidance for the year ahead.
Fourth-quarter earnings for S&P 500 companies are significantly outperforming expectations, led by robust growth in industrial and tech sectors, as investors await a busy week of corporate results and key economic data.
Alliance Resource Partners (ARLP) reported robust fourth-quarter earnings, driven by cost discipline and a resilient coal market. The company provided optimistic 2026 guidance, citing strengthening demand from data centers, industrial growth, and recent winter storms that underscored coal's critical role in grid reliability.
